Wednesday, August 26, 2026
TagsPhase

Tag: Phase

Entertainment

Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata

BFN's Desk - 0
Entertainment

Skyhawk Therapeutics Receives HREC Approval for a Phase 1 Study of its SKY-0515 RNA-Targeting Small Molecule for Huntington's Disease

BFN's Desk - 0
Automobile

Adiso Therapeutics Announces Positive Topline Data from Phase 1b Study of ADS051 for the Treatment of Moderate-to-Severe Ulcerative Colitis

BFN's Desk - 0
Automobile

Final Multivariate Analysis from the Phase 3 MAGNITUDE Study Shows Trend Toward Improvement in Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer with...

BFN's Desk - 0
Automobile

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the European Society of Medical Oncology 2023 Congress

BFN's Desk - 0
Politics

Sagar Parikrama Phase X concluded with physical participation of more than 2000 fishermen and women, FFPOs, Entrepreneurs and other stake holders at Fish Food...

BFN's Desk - 0
Politics

Union Minister for Fisheries, Animal Husbandry & Dairying, Shri Parshottam Rupala to start Sagar Parikrama Phase X today

BFN's Desk - 0
Entertainment

ALLORION THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1/2 STUDY OF ARTS-021, A POTENTIAL BEST IN CLASS CDK2 INHIBITOR, FOR ADVANCED OR METASTATIC SOLID...

BFN's Desk - 0
Entertainment

Scorpion Therapeutics and Pierre Fabre Laboratories Announce First Patient Dosed in Phase 1/2 Clinical Trial of STX-721, a Mutant-Selective EGFR Exon 20 Inhibitor for...

BFN's Desk - 0
Politics

Sagar Parikarma Phase IX initiative would help to meet fishermen at their doorsteps, hear their difficulties and grievances, witness village level ground realities, encourage...

BFN's Desk - 0
1...78910Page 8 of 10

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Newspaper is your news, entertainment, music fashion website. We provide you with the latest breaking news and videos straight from the entertainment industry.

Contact us: [email protected]

FOLLOW US

© Newspaper WordPress Theme by TagDiv